Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of TauroLock in prevention of catheter-related infection
IRCT20240821062823N1Phase 4Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of taurolidine in catheter infection and catheter-related thrombosis (CRT), sponsored by Shahid Sadoughi University of Medical Sciences. Started Aug 2024; status: completed.
02
Drugs
taurolidine
03
Conditions
catheter infectioncatheter-related thrombosis (CRT)
Beyond the preview
Go deeper on IRCT20240821062823N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240821062823N1.